The suit alleges that Purdue did not accurately represent the addictive qualities of OxyContin in their marketing campaigns and overstated the benefits of using opioids to treat chronic pain. It is still unknown what kinds of damages New Hampshire is seeking.
“We share New Hampshire officials’ concerns about the opioid crisis and we are committed to working collaboratively to find solutions,” Purdue said in a statement, though they denied any wrongdoing.
More Articles on Opioids:
Opioid overdose deaths could be higher than CDC numbers indicate, study finds
Physicians from lower-tier med schools prescribe more opioids
Insys Therapeutics may settle Illinois opioid lawsuit for up to $4.5M: 5 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.